Rho site logo

Rho Named a Best CRO with Life Sciences Award from the Triangle Business Journal

Published 05/27/15


For Immediate Release

Chapel Hill, NC  ̶  May 27, 2015  ̶  Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that the company was recognized as one of the Best CROs by the Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham, Chapel Hill region of North Carolina, where Rho is headquartered. 

Part of the publication’s annual Life Sciences Awards, the Best CRO recognizes individuals and organizations breaking ground in the life sciences industry. This year’s winners were selected to reflect the power, influence and intellect present in the biology, biotechnology, genomics, neuroscience and pharmacology community in the Research Triangle Park (RTP) area of North Carolina. 

“It is an honor to be included among the top life science industry leaders in the RTP region,” said Laura Helms Recce, Dr. P.H., chief executive officer for Rho.  "This award is a testament to Rho’s commitment to exceptional service, and to our agility and adaptability in providing customers the clinical trial support they need. As an employee-focused CRO grounded in North Carolina, we are dedicated to growing the life sciences industry and helping improve the business climate, both in the RTP region and across the state.”

Rho is one of 15 companies selected for the Life Sciences Award. Rho and the other winners were recognized at an awards luncheon held May 21, 2015, in Cary, North Carolina. 

To learn more about Rho, please visit www.rhoworld.com.

About Rho

Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more 31 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Twitter.


PDF Click here to download